High-Sensitivity Assays for Troponin in Patients with Cardiac Disease !

Troponin is a widely used biomarker in patients with cardiac disease. The use of troponin is well established in patients with suspected acute myocardial infarction (AMI), but troponin measurement is also used in other acute and nonacute settings. In patients with suspected AMI, early decision-making is crucial to allow rapid treatment and further diagnostic evaluation. Current guidelines recommend serial measurements of troponin with a cut-off concentration at the 99th percentile to triage patients in the emergency department.

Newer, high-sensitivity assays for troponin enable the detection of distinctly lower concentrations. Using these assays and very low cut-off concentrations, several rapid diagnostic strategies have been reported to improve diagnosis in acute cardiac care. Furthermore, noncoronary and non-acute applications of troponin assays — for example as a biomarker in patients with heart failure, pulmonary embolism, or stable coronary artery disease — are on the horizon and might improve individual risk stratification.

In this Review, we provide an overview on the development of high-sensitivity assays for troponin, and their application in patients with cardiac disease.

Pathophysiological background of troponin and troponin release

in different settings. A schematic overview of myocardial structure

related to troponin (inset), as well as the plasma troponin concentrations 

in different clinical settings (young and healthy, elderly or chronic diseases,

myocardial injury, and myocardial infarction).

Read more: High-Sensitivity Assays for Troponin in Patients with Cardiac Disease !

Source: NatureReviewsCadiology

Download in PDF

How Body Fat May Make You More Prone to This Cancer

Most of the time people try to lose a few pounds so they like that reflection in the mirror a little more, but it turns out the benefits of weight loss may extend well beyond looking better in your swimsuit.

A new study suggests that, if you’re an older woman, shedding excess pounds may also reduce your risk of developing endometrial cancer, a potentially deadly disease with which tens of thousands of women are diagnosed each year.

Read more: How Body Fat May Make You More Prone to This Cancer

A close-up image of a slim young woman with a belly fat after giving birth. Woman's torso with
some belly fat. Abdominal fat.

Source: msn.com/en-us/health/medical

Blood Tests for Prion Disease.

Two studies describe methods for detecting these misfolded proteins in human blood samples.

Thousands of Europeans may be asymptomatic carriers of variant Creutzfeldt-Jakob disease (vCJD), a fatal prion disease that is the human variant of Mad Cow disease. But now, two studies published December 21 in Science Translational Medicine describe new methods for detecting even latent vCJD, which could make blood transfusions safer and help early detection and treatment of the disease.

The blood tests accurately diagnosed 32 patients between the two studies, distinguishing those with the disease from 391 healthy controls. In both cases, the tests were 100 percent sensitive and 100 percent specific and, in one of the studies, the test managed to identify vCJD prion particles in a blood donation more than a year before the onset of symptoms—a first for prion disease detection.

Read more: Blood Tests for Prion Disease.

Source: TheScientist

Unnecessary Endoscopies Could Be Avoided with Fecal Blood Test

The majority of primary care patients referred for bowel endoscopy do not have significant colorectal disease (SCD), and are unnecessarily exposed to a small but realistic risk of severe endoscopy-associated complications.

Serious colorectal diseases, including colorectal cancer, are difficult to diagnose as the signs and symptoms are not always clear.

Read more: Unnecessary Endoscopies Could Be Avoided with Fecal Blood Test

The Quantum Blue rapid test allow for the immediate measurement of fecal calprotectin
(Photo courtesy of Bühlmann Laboratories).

Source: LabMedica

From 230,000 patients to extinct in 15 years: pathology and new drugs key to defeating hepatitis C

An estimated 230,000 Australians have chronic hepatitis C, and a quarter of cases are undiagnosed.

Hepatitis C inflames the liver and unlike the A and B viruses there is no vaccine available. Pathology is important for diagnosing the virus.

Many people with hepatitis C may not experience symptoms, but left untreated the disease can cause cirrhosis (scarring of the liver), which in a small number of cases can lead to liver cancer.

Read more: From 230,000 patients to extinct in 15 years: pathology and new drugs key to defeating hepatitis C

Source: knowpathology

Cancer: Four-Stranded DNA Could Help Develop Targeted Treatments

By taking a closer look at four-stranded versions of DNA inside the genome of human cells, scientists have discovered some potential new avenues for targeted cancer treatments. They found that the quadruple helix structures occur in DNA regions that control genes, especially cancer genes.

The researchers, from the University of Cambridge in the United Kingdom, report their findings in the journal Nature Genetics.

Targeted cancer therapies are currently the focus of much research and development into new anticancer treatments.

They are an important area of precision medicine - where information about an individual patient's genes and proteins are used to prevent, diagnose, and treat disease.

Read more: Cancer: Four-Stranded DNA Could Help Develop Targeted Treatments

The aim of targeted therapy is to attack cancer cells without affecting healthy cells.

Source: MedicalNewsToday

Validating the Performance of Body Fluid Specimens

In health care, the analysis of body fluids plays an important role in the diagnosis and management of a wide variety of conditions. Traditionally, clinical laboratorians have provided analysis of body fluid specimens without question while also recognizing the sometimes difficult work that goes into their collection. As standards for method validation and laboratory developed tests (LDTs) evolve, the analysis of body fluids is receiving increased attention from both laboratories and regulatory bodies.

The clinical laboratory’s overarching goal is to ensure accurate test results from all specimens. Therefore, it is the responsibility of every laboratory to investigate the analytical performance of the tests performed on the various fluid types accepted and to provide a context for result interpretation.

Read more: Validating the Performance of Body Fluid Specimens

Source: medlabmag

How To Prevent and Treat Fatty Liver

I have a Fatty Liver- Now what?

Many of my clients have digestive issues and think it is to do with a food they are eating. Sometimes they opt for allergy testing, others get blood work or an ultrasound done to see if there are any serious problems.

More and more clients are been diagnosed with a fatty liver and ask me now what do I do?

What is a fatty liver?

A fatty liver is the result of excess fat in the liver. This fat builds up when a person’s diet exceeds the amount of fat their body can handle. Having a fatty liver can lead to fatty liver disease, which then leads to chronic illnesses. Many who are overweight, have belly fat, are insulin resistant, pre- diabetic and who crave sugars and starches are likely have a fatty liver. Yet many who are ultimately healthy and not overweight are finding they to, have a fatty liver.

Read more: How To Prevent and Treat Fatty Liver

Source: justnaturallyhealthy

Electrical Immunosensor Detects Acute Myocardial Infarction

Heart disease and especially acute myocardial infarction (AMI) are the leading causes of death for both men and women and therefore, a fast and reliable diagnosis of heart attack or cardiac episode are urgently needed.

The most commonly used biomarkers are creatine kinase-MB, myoglobin, cardiac troponin T, and cardiac troponin I (cTnI), which is a subunit of the troponin complex found in cardiac muscle and is a highly specific and sensitive biomarker for the clinical diagnosis of AMI.

Read more: Electrical Immunosensor Detects Acute Myocardial Infarction

The core material used for the new immunosensor that detects proteins in the blood stream following

a heart attack, providing results in just one minute (Photo courtesy of Ulsan National Institute of

Science and Technology).

Source: labmedica

If You Are In Danger Of BREAST CANCER, Your Body Will Give You These 5 Signs!

Invasive breast cancer affects 1 in 8 women in the US only. It’s the type of cancer with the highest incidence among women. According to the American Cancer Society, by the end of 2016, 246,660 new cases of invasive breast cancer will be diagnosed in America, 40,450 of which will be terminal.

Detecting the cancer early significantly increases the chances of successful treatment. Knowing the early signs and symptoms of invasive breast cancer can help you detect it in its early stages.

1. FATIGUE

Fatigue is a common symptom in many types of cancer, including breast cancer. The thing is this type of fatigue cannot be alleviated by sleep or rest. Cancer-related fatigue is not caused by physical strain and is often accompanied by other symptoms such as pain, sleep disturbance and depression. This fatigue is caused by an imbalance of chemicals in the body the cancer creates, according to scientists.

Read more: If You Are In Danger Of BREAST CANCER, Your Body Will Give You These 5 Signs!

Source: healthylivingstyle

Watch: Female Breast Exam 

Chronic Kidney Disease

WHAT IS CHRONIC KIDNEY DISEASE?

The kidneys function as blood filters that drain waste products while retaining other valuable blood contents like proteins. If these filters are damaged, they initially may become “leaky,” and substances like proteins can seep from blood into urine. At later stages, these filters slowly shut down and lose their ability to filter. When kidney impairment lasts for more than 3 months, it is called chronic kidney disease. This process ultimately results in decreased urine production and kidney failure, with buildup of waste products in the blood and body tissues. One common reason for kidney failure in the United States is diabetes.

Sometimes chronic kidney disease is accompanied by high blood pressure, which not only can be caused by kidney damage but also further accelerates kidney injury and is a major reason for the negative effects of chronic kidney disease on other organs, including increased risk of heart disease and stroke, collection of excess body fluids, anemia, weakening of bones, and impairment of the way the body eliminates medications.

Read more: Chronic Kidney Disease

It is estimated that 1 in 10 US adults has chronic kidney disease, and many who have
he disease are not aware of it.

Source: jamanetwork

Diagnosis of Pneumocystis jirovecii pneumonia

Diagnosis of Pneumocystis jirovecii pneumonia (PCP) is conventionally based on direct staining and visualization. Challenges in obtaining alveolar samples have stimulated interest in techniques for detection of Pneumocystis DNA in non-invasive samples, which can give good sensitivity and specificity. Robust diagnosis is key to ensuring appropriate therapy.

Introduction

Pneumocystis jirovecii (previously Pneumocystis carinii) is a pathogen capable of causing life threatening Pneumocystis pneumonia (PCP) in the immunocompromised with case fatality rates among those hospitalized of around 10%. PCP typically occurs in individuals with hematological malignancies on chemotherapy or with other causes of acquired cellular immunodeficiency or, most frequently, in human immunodeficiency virus (HIV)-positive individuals with CD4 T-cell counts <200 cells/µL or <14% of total white cell count. First-line treatment is co-trimoxazole, a combination of the antibiotics sulfamethoxazole and trimethoprim, at high dose for 3 weeks, which has the clinically significant potential side effects of bone marrow suppression, rash and bronchial hypersensitivity.

Read more: Diagnosis of Pneumocystis jirovecii pneumonia

Source: ClinicalLaboratoryInternational

Appendicitis: Warning Signs and Early Symptoms

Appendicitis is a condition in which the appendix becomes inflamed. Its symptoms can become very uncomfortable, painful, and potentially life-threatening if left untreated.

Sudden appendicitis is the most common cause of acute abdominal pain requiring surgery in the United States. Additionally, more than 5 percent of the population develops appendicitis at some point.

Though it most commonly occurs between the ages of 10 and 30, appendicitis can develop at any age.

Read more: Appendicitis: Warning Signs and Early Symptoms

The appendix is a tube-shaped piece of tissue attached to part of the long intestine and severe pain is
often the first symptom of appendicitis. In most cases, it will begin near the belly button and surgery
may be needed to treat a case of appendicitis.

Source: medicalnewstoday

Throat Cancer: Get the Facts

The throat is often described as having many different parts. This article looks at two of the more common places throat cancer can occur: the pharynx and the larynx.

1. The pharynx is most commonly thought of as the throat. It is a tube around 5 inches long that leads from behind the nose to the food pipe.
2. 
   
3. The larynx is also known as the voicebox. It is a short passage just below the pharynx. The larynx holds the vocal cords and a small piece of tissue called the epiglottis.

The epiglottis moves to cover the top of the larynx so food cannot enter it when people breathe.

Read more: Throat Cancer: Get the Facts

Cancer in the throat is uncommon when compared with other forms of cancer. Early symptoms of
throat cancer include a long-lasting cough and pain when swallowing.

Source: medicalnewstoday

What is an Inguinal Hernia?

The abdominal cavity is the large hollow space in the body that contains many important organs such as the stomach and liver. An inguinal hernia occurs when part of the abdominal cavity pushes into an area of the body called the inguinal canal.

There are two inguinal canals in the body, one on either side of the groin. Different structures of the body pass through the inguinal canal depending on the person's gender.

In men, the spermatic cord passes through the canal and connects to the testicles. In women, round ligaments that support the uterus pass through the canal.

An inguinal hernia usually affects either the small intestine or the fatty tissue in the abdomen.

Read more: What is an Inguinal Hernia?

Around a quarter of men will have an inguinal hernia at some point in their lives.
Incarcerated or strangulated hernias can cause extreme pain, nausea, and vomiting. 
The only available treatment for an inguinal hernia is surgery.

Source: medicalnewstoday

Medical Video: How does insulin work in the body

Take a trip inside the body in this fascinating animated video to find out how insulin works in the body.

Source: MedicalVideos

New gene testing method can identify mutations, prioritize variants in breast and ovarian cancer genes

A research team led by an award-winning genomicist at Western University has developed a new method for identifying mutations and prioritizing variants in breast and ovarian cancer genes, which will not only reduce the number of possible variants for doctors to investigate, but also increase the number of patients that are properly diagnosed.

These potentially game-changing technologies, developed by Peter Rogan, PhD, students and his collaborators from Western's Schulich School of Medicine & Dentistry, reveal gene variants that were missed by conventional genetic testing.

Their method, described in BMC Medical Genomics, was first applied to 102 individuals at risk or with a diagnosis of inherited breast cancer. The team also studied 287 women with no known mutations for an article published in Human Mutation.

Rogan, Canada Research Chair in Genome Bioinformatics, says that 16 to 20 per cent of women in southwestern Ontario, who have their BRCA genes tested for breast and/or ovarian cancer risk, carry disease-causing gene variants that are well-understood by clinicians and genetic counselors. If a patient tests positive for an abnormal BRCA1 or BRCA2 gene and have never had breast cancer, there is a much higher-than-average risk of developing the deadly disease.

Read more: New gene testing method can identify mutations, prioritize variants in breast and ovarian cancer genes

Source: azonano

Latest progress in diagnosis and treatment of Sarcomas

What are sarcomas?

Sarcomas are rare tumours of connective tissue, and as a result they can affect any part of the body. These are tumours of fat, nerves, bone, tendons, muscle and skin. They account for about 1% of all adult cancers and approximately 15% of pediatric tumours. In addition to the wide distribution of potential primary sites and the rarity, these are also very heterogeneous tumours with over 80 different histological subtypes.

These 3 factors make sarcomas extremely challenging to treat. Consequently, it is very important that sarcoma patients are managed by an experienced multi-disciplinary team, including surgeons, pathologists, radiologists, oncologists, specialist nurses, physiotherapists and pharmacists.

Diagnosis

In order to make the diagnosis a biopsy is required to confirm the presence of a sarcoma and the specific subtype. Because these tumours are so rare and heterogeneous it is essential that an experienced pathologist reviews the biopsy sample. Initial diagnostic radiology tests can include a CT and MRI scan depending on the location and type of sarcoma.

Treatment

The mainstay of treatment of localized sarcomas includes complete surgical removal with or without radiation. It is important that an experienced surgeon performs surgery as improperly performed surgery can have an impact on outcome.

Read more: Latest progress in diagnosis and treatment of Sarcomas

A sarcoma is a cancer. Sarcoma - malignant tumors made of cancellous bone, cartilage,

fat, muscle, vascular, and tissues.

Source: Designua/Shutterstock

Acid-Fast Stain Identifies Schistosoma Eggs

Schistosomiasis, also known as snail fever, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected and signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine.

Microscopic identification of eggs in stool or urine is the most practical method for diagnosis. Stool examination is performed when infection with Schistosoma mansoni or S. japonicum is suspected, and urine examination should be performed if S. haematobium is suspected. Eggs can be present in the stool in infections with all Schistosoma species.

Scientists at the University of Lisbon examined whether the Ziehl–Neelsen (ZN) stain, also known as the acid- fast stain, would be helpful in detection and identification of Schistosoma eggs. In histological sections, S. mansoni eggshells appear as ZN positive and S. haematobium shells as ZN negative. The staining target of the responsible ZN component (carbolfuchsin) in the shell is unknown and because carbolfuchsin is supposed to stain mycolic acids in the mycobacterial cell wall, unidentified substances in the eggshell were proposed as target. Fuchsin is a known nucleic acid stain, and it was already shown that mycobacteria with insufficiently retained carbolfuchsin may be invisible in bright-field microscopy; yet, they can be easily detected because of a strong red fluorescence when excited with green light.

Read more: Acid-Fast Stain Identifies Schistosoma Eggs

Positive staining of Schistosoma mansoni eggs

Source: ganfyd

Colorectal cancer

Colorectal cancer had a low incidence several decades ago. However, it has become a predominant cancer and now accounts for approximately 10% of cancer-related mortality in western countries. The ‘rise’ of colorectal cancer in developed countries can be attributed to the increasingly ageing population, unfavourable modern dietary habits and an increase in risk factors, such as smoking, low physical exercise and obesity. New treatments for primary and metastatic colorectal cancer have emerged, providing additional options for patients; these treatments include laparoscopic surgery for primary disease, more-aggressive resection of metastatic disease (such as liver and pulmonary metastases), radiotherapy for rectal cancer, and neoadjuvant and palliative chemotherapies. However, these new treatment options have had limited impact on cure rates and long-term survival. For these reasons, and the recognition that colorectal cancer is long preceded by a polypoid precursor, screening programmes have gained momentum. This Primer provides an overview of the current state of the art of knowledge on the epidemiology and mechanisms of colorectal cancer, as well as on diagnosis and treatment.

Introduction

We live in an era with improved worldwide average living standards and increased access to adequate health care that has considerably improved the diagnosis and treatment of diseases. These measures have had an effect on the average life expectancy in most regions of the world. However, although death rates from communicable diseases have improved globally as a result of these medical improvements, cancer-related mortality has increased by almost 40% over the past 40 years. A further 60% increase is expected in the next 15 years, with 13 million people estimated to die of cancer in 2030. The main causes of cancer-related mortality have also changed, attributable to alterations in disease incidence, the introduction of screening programmes and therapeutic improvements. Colorectal cancer was rather rare in 1950, but has become a predominant cancer in western countries, now accounting for approximately 10% of cancer-related mortality. Reasons explaining this increased incidence include an ageing population and the preponderance of poor dietary habits, smoking, low physical activity and obesity in western countries. The change in incidence is not only apparent in the rates of sporadic disease but also in some familial cancer syndromes. Indeed, given that the rates of Helicobacter pyloriinfection (a causative factor of gastric cancer) have fallen dramatically, colorectal cancer is now the predominant presentation of Lynch syndrome (a hereditary non-polyposis type of colorectal cancer), whereas carriers of this syndrome used to be predominantly affected by gastric cancer.

Read more: Colorectal cancer

Source: krmc